OGD Updates July 2019 Metrics
The Office of Generic Drugs provided an update late last night to its Activities Report of the Generic Drugs Program (FY 2019) Monthly Performance (here). Not too many surprises, but there are a couple of numbers that are of interest. Let’s start with refuse-to-receive (RTR) actions. There were only two RTR actions in July (both […]